Načítá se...
New anti-tuberculosis drugs and regimens: 2015 update
Over 480 000 cases of multidrug-resistant (MDR) tuberculosis (TB) occur every year globally, 9% of them being affected by extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. The treatment of MDR/XDR-TB is unfortunately long, toxic and expensive, and the success rate largely unsat...
Uloženo v:
| Vydáno v: | ERJ Open Res |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Respiratory Society
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5005131/ https://ncbi.nlm.nih.gov/pubmed/27730131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00010-2015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|